Karus Therapeutics Ltd
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested β papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: βPharmacokinetics of KA2237, a novel selective inhibitor of PI3K-Ξ² and PI3K-Ξ΄, in patients: A first-in-human study using PK modelling to predict drug concentrations during dose escalationβ.
Graham Trevitt, Elisabeth Bone, Kemal Haque, Loretta Nastoupil, Elisabeth A. Bone +2 more